Nancy Y Lee Selected Research

Head and Neck Neoplasms (Head and Neck Cancer)

5/2022	Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation Oncology.
1/2022	Outcomes following head and neck cancer surgery among older adults as determined by an electronic geriatric assessment.
12/2021	The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancers.
1/2021	Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers.
1/2021	Case study of the integration of electronic patient-reported outcomes as standard of care in a head and neck oncology practice: Obstacles and opportunities.
1/2021	Patient selection for immunotherapy in head and neck cancer - Authors' reply.
11/2020	Past, present and future of proton therapy for head and neck cancer.
1/2020	Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base.
1/2020	Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.
10/2019	Human papillomavirus 16 promotes microhomology-mediated end-joining.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nancy Y Lee Research Topics

Disease

83	Neoplasms (Cancer) 11/2022 - 02/2006
56	Head and Neck Neoplasms (Head and Neck Cancer) 05/2022 - 06/2005
34	Squamous Cell Carcinoma of Head and Neck 01/2022 - 04/2008
15	Neoplasm Metastasis (Metastasis) 11/2022 - 10/2007
15	Carcinoma (Carcinomatosis) 03/2022 - 02/2006
15	Oropharyngeal Neoplasms 12/2021 - 02/2006
10	Thyroid Neoplasms (Thyroid Cancer) 09/2022 - 12/2005
10	Hypoxia (Hypoxemia) 08/2021 - 01/2008
10	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2014
8	Nasopharyngeal Carcinoma 01/2021 - 06/2010
5	Deglutition Disorders (Dysphagia) 01/2022 - 12/2012
5	Trismus (Lockjaw) 01/2022 - 01/2016
5	Xerostomia 04/2017 - 02/2006
5	Melanoma (Melanoma, Malignant) 01/2016 - 06/2010
4	Osteoradionecrosis 01/2020 - 11/2011
3	Anaplastic Thyroid Carcinoma 01/2022 - 12/2011
3	Mucositis 11/2021 - 12/2012
3	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2021 - 01/2019
3	Rupture 01/2021 - 10/2007
3	Necrosis 01/2020 - 10/2007
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2017 - 10/2012
3	Pathologic Constriction (Stenosis) 03/2008 - 02/2006
2	Skin Neoplasms (Skin Cancer) 01/2022 - 01/2020
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2020
2	Margins of Excision 01/2017 - 11/2013
2	medullary Thyroid cancer 09/2014 - 05/2010
2	Laryngeal Neoplasms (Laryngeal Cancer) 07/2012 - 10/2007
2	Disease Progression 12/2011 - 11/2009
2	Paranasal Sinus Neoplasms 04/2008 - 03/2007
1	Frailty 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Chondrosarcoma 01/2022
1	Dermatitis 11/2021
1	Inflammation (Inflammations) 01/2021
1	Neutropenia 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Facial Pain (Myofacial Pain) 01/2020
1	Rhabdomyosarcoma 01/2020
1	COVID-19 01/2020
1	Stomatitis 01/2020
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2018
1	Chromosomal Instability (Chromosome Stability) 01/2018
1	Bites and Stings (Sting) 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2017
1	Papillomavirus Infections 12/2016

Drug/Important Bio-Agent (IBA)

10	Protons (Proton)IBA 11/2022 - 01/2012
10	fluoromisonidazoleIBA 08/2021 - 01/2008
9	Biomarkers (Surrogate Marker)IBA 08/2021 - 10/2012
7	PlatinumIBA 01/2020 - 10/2007
6	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 12/2016
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 10/2012
5	Biological ProductsIBA 11/2020 - 10/2012
4	Cetuximab (Erbitux)FDA Link 01/2020 - 01/2014
3	pembrolizumabIBA 01/2022 - 01/2019
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 04/2008
3	Bevacizumab (Avastin)FDA Link 01/2016 - 02/2012
2	IodineIBA 09/2022 - 04/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 12/2011
2	avelumabIBA 01/2021 - 03/2019
2	AntigensIBA 01/2021 - 02/2013
2	NivolumabIBA 03/2019 - 01/2019
1	durvalumabIBA 01/2022
1	tremelimumabIBA 01/2022
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2022
1	3- fluoro- 2- (4- ((2- nitro- 1H- imidazol- 1- yl)methyl)- 1H- 1,2,3- triazol- 1- yl)propan- 1- olIBA 12/2020
1	AlpelisibIBA 01/2020
1	Radiation-Sensitizing AgentsIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 10/2019
1	fluoroerythronitroimidazoleIBA 10/2019
1	RNA (Ribonucleic Acid)IBA 03/2019
1	Viral DNAIBA 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2018
1	InterferonsIBA 01/2018
1	oleyloxyethylphosphorylcholineIBA 09/2016
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2016

Therapy/Procedure

104	Radiotherapy 11/2022 - 06/2005
37	Therapeutics 09/2022 - 04/2008
27	Drug Therapy (Chemotherapy) 01/2022 - 11/2006
24	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2017 - 02/2006
16	Proton Therapy 01/2022 - 02/2016
14	Chemoradiotherapy 03/2022 - 04/2008
14	Re-Irradiation 01/2021 - 12/2011
6	Immunotherapy 01/2021 - 02/2013
4	Aftercare (After-Treatment) 01/2021 - 02/2006
4	Enteral Nutrition (Feeding, Tube) 01/2021 - 06/2015
4	Gastrostomy 01/2015 - 10/2007
3	Combined Modality Therapy 03/2016 - 04/2008
3	Neck Dissection (Radical Neck Dissection) 12/2015 - 04/2008
2	Drug Tapering 01/2020 - 03/2019
2	Tracheostomy 01/2018 - 01/2018
1	Craniospinal Irradiation 11/2022
1	Adjuvant Radiotherapy 01/2022
1	Length of Stay 01/2022
1	Time-to-Treatment 05/2021
1	Treatment Delay 01/2020
1	Retreatment 01/2020
1	X-Ray Therapy 01/2018